Publications in collaboration with researchers from University of Lorraine (2)

2023

  1. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

    Journal of Crohn's and Colitis

2022

  1. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 4, pp. 294-306